Fundraising Fox

Vignette Bio

San Diego, US · Founded 2023 · Delaware corporation · 3 known investors

Healthtech

Founders & leadership

KS
Kenneth Song, M.D.Named on SEC filing

Investors · 3

Foresite CapitalreportedWest Hollywood
Qiming Venture PartnersreportedBeijing · $5M – $134M
Samsara BioCapitalreportedPalo Alto

Reported raises · per SEC filings

Form D private placements

$105M disclosed across 1 round · 2024

▶$105MraisedSep 2024 · 56 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kenneth Song, M.D.Executive Officer, Director
Offering amount
$105M
Amount sold
$105M
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Candid Debuts With $370M, Targets Leadership in T Cell Engager Space - BioSpacebiospace.com · Sep 2024Candid Therapeutics Launches with $370M to Advance Bispecific T-Cell Engagers for Autoimmune Diseasestrial.medpath.com · Sep 2024Candid, with $370M, sets out to prove bispecifics’ worth in autoimmune disease | BioPharma Divebiopharmadive.com · Sep 2024Candid Therapeutics Debuts with $370M Capital Raise to Clinically Evaluate Potentially Transformative Autoimmune Therapiesbusinesswire.com · Sep 2024Candid Therapeutics Debuts with $370M Backed by Top Life Science VCsbusinessofsandiego.substack.com · Sep 2024Cooley Advises on Candid Therapeutics’ $370 Million Capital Raise, Three-Way Merger // Cooley // Global Law Firmcooley.com · Sep 2024

Frequently asked questions

Who are Vignette Bio's investors?
Vignette Bio's investors include Foresite Capital, Qiming Venture Partners, Samsara BioCapital.
How much funding has Vignette Bio raised?
Vignette Bio has disclosed $105M raised across 1 round.
Where is Vignette Bio headquartered?
Vignette Bio is headquartered in San Diego, US.